"The
Report Follicular Lymphoma Global Clinical Trials Review, H1, 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz”
GlobalData's
clinical trial report, Follicular Lymphoma Global Clinical Trials
Review, H1, 2016" provides an overview of Follicular Lymphoma
clinical trials scenario. This report provides top line data relating
to the clinical trials on
Follicular Lymphoma.
Report includes an overview of trial numbers and their average
enrollment in top countries conducted across the globe. The report
offers coverage of disease clinical trials by region, country (G7 &
E7), phase, trial status, end points status and sponsor type. Report
also provides prominent drugs for in-progress trials (based on number
of ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download Sample copy of this
Report at
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Read our latest Press
Release at http://www.marketresearchreports.biz/pressreleases
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing
to Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Five Countries Contributing
to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing
to Clinical Trials in Central and South America 13
Clinical Trials by G7
Countries: Proportion of Follicular Lymphoma to Oncology Clinical
Trials 14
Clinical Trials by Phase in G7
Countries 15
Clinical Trials in G7 Countries
by Trial Status 16
Clinical Trials by E7
Countries: Proportion of Follicular Lymphoma to Oncology Clinical
Trials 17
Clinical Trials by Phase in E7
Countries 18
Clinical Trials in E7 Countries
by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status
22
Clinical Trials by End Point
Status 23
Subjects Recruited Over a
Period of Time 24
Clinical Trials by Sponsor Type
25
Prominent Sponsors 26
Top Companies Participating in
Follicular Lymphoma Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on
Follicular Lymphoma 29
May 18, 2016: AbbVie To Present
Data on Duvelisib at ASCO 2016 29
May 12, 2016: Epizyme to
Present Data From the Tazemetostat Non-Hodgkin Lymphoma Program at
American Society for Hematology Meeting on Lymphoma Biology 29
Mar 17, 2016: Information
Update - International clinical trials, including trials in Canada,
are being stopped due to serious adverse events with the drug
Zydelig, in combination with other cancer drugs 30
Mar 09, 2016: Genmab Achieves
Second Milestone in Daratumumab NHL Study Under Collaboration with
Janssen 30
Feb 25, 2016: Seattle Genetics
Initiates Phase I Trial of SGN-CD19B for Patients with B-cell
Non-Hodgkin Lymphoma 31
Clinical Trial Profile
Snapshots 32
Appendix 772
Abbreviations 772
Definitions 772
Research Methodology 773
Secondary Research 773
About GlobalData 774
Contact Us 774
Disclaimer 774
Source 775
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment